YAP1 and hepatocellular carcinoma: For instance, viscoelasticity has been shown to affect the behavior of HCC cells, where advanced glycation end‐products (AGEs) in the ECM enhance viscoelastic properties, promoting HCC progression through a mechanotransduction pathway involving integrin‐β1 and YAP signaling.